Nephrology Flashcards
common causes of non-gap metabolic acidosis
acetazolamide topiramate chemotherapy- ex cisplatin abx- aminoglycosides, bactrim amphotericin b lithium rifampin inhaled toluene pentamidine
medical management of bilateral RAS
- ACE/ARB and diuretic
- do this prior to considering angiography and stenting
causes of AIN
drugs- abx, NSAIDS, PPIs
infections- legionella, strep
- systemic/autoimmune disease- ex. sjogrens, SLE
clinical features and lab findings of AIN
rash, fever, allergic sx.
new drug exposure
eosinophilia or urinary eosinophils, though these are not necessary
urine sediment with pyuria, WBC casts, hematuria, varying proteinuria, however can also be normal
ESRD daily phos restriction?
900 mg/day
ESRD choice of phos binder?
if Ca <9.5, calcium carbonate or acetate
> 9.5, sevelamer or lanthanum
if ESRD patient is restricting dietary phos, on a phos binder, and PTH remains >300, what next?
if serum phos <5.5, and serum ca<9.5 –> vit D analog
if serum phos <5.5 and serum ca>9.5, or if serum phos is >5.5 –> cinacalcet
How do calcimimetics like cinacalcet work?
increase the sensitivity of calcium sensing receptors on parathyroid glands and reduce serum PTH, ca and phos
pathology findings of HSP in kidneys?
IgA immune complex deposition in small vessels and mesangium
how does malabsorption in bariatric surgery pts or those with small bowel malabsorption issues lead to increased risk of kidney stones?
increased urinary oxalate: fat binds to calcium and leaves oxalate to be renally excreted or absorbed by colon
low urinary citrate: unclear pathophys, may be 2/2 hypokalemia leading to increased citrate absorption in kidney. citrate is an inhibitor of kidney stones
How does polyoma virus (BK type) present in renal transplant pts?
most commonly after rejection and significant immunosuppression
patients develop tubulointerstitial nephritis w/ rising creatinine and intranuclear inclusions in urine cells
clinical features of goodpasture syndrome?
pulmonary hemorrhage and glomerulonephritis
anti-GBM ab
dietary interventions to reduce risk of calcium oxalate kidney stones?
decrease sodium decrease animal protein increase calcium- dietary, not supplemental (decreases oxalate absorption in GI tract) increase fluids increase citrate/fruits and vegetables
extrarenal manifestations of polycystic kidney disease
hepatic cysts, pancreatic cysts, cerebral aneurysms, cardiac valvular disease and diverticulosis
metabolic acidosis algorithm:
high anion gap w/ ketones
DKA
starvation
EtOH